Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:526837.
doi: 10.1155/2013/526837. Epub 2013 Aug 1.

CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents

Ewa Emich-Widera  1 , Wirginia Likus, Beata Kazek, Paweł Niemiec, Anna Balcerzyk, Aleksander L Sieroń, Iwona Zak
Affiliations

CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents

Ewa Emich-Widera et al. Biomed Res Int. 2013.

Abstract

Drug-resistant epilepsies still remain one of the most profound problems of contemporary epileptology. Several mechanisms of drug resistance are possible; among them, genetic factors have a prominent place. Much importance is attached to genes, which encode enzymes that metabolize antiepileptic drugs CYP 3A, which belong to the family of cytochromes P450 and the genome of multidrug resistance, such as multidrug resistance 1 (MDR1) that expresses P-glycoprotein (P-gp), a drug transporter protein. The aim of the study was to assess the relation between polymorphism of gene CYP3A5 and polymorphism C3435T of MDR1 gene with the occurrence of focal, drug-resistant epilepsy in children and youths up to 18 years of age. The study comprised 85 patients, and their age range was from 33 months to 18 years of age, suffering from epilepsy, partly responding well to treatment, partly drug resistant. The polymorphism of both genes has been analysed using the PCR-RFLP method. The study failed to corroborate association between polymorphism CYP3A5*3 and C3435T polymorphism in MDR1 gene and pharmacoresistant epilepsy. The results of our research do not confirm the prognostic value of the polymorphisms examined in the prognostication of drug resistance in epilepsies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PCR-RFLP analyses for C3435T polymorphism MDR1 (a) and CYP3A5 variant alleles (b).
See this image and copyright information in PMC

References

    1. Adelöw C, Åndell E, Åmark P, et al. Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: First report from the Stockholm Incidence Registry of Epilepsy (SIRE) Epilepsia. 2009;50:1094–1101. - PubMed
    1. Begley CE, Baker GA, Beghi E, et al. Cross-country measures for monitoring epilepsy care. Epilepsia. 2007;48(5):990–1001. - PubMed
    1. Kwong KL, Sung WY, Wong SN, So KT. Early predictors of medical intractability in childhood epilepsy. Pediatric Neurology. 2003;29(1):46–52. - PubMed
    1. Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Research. 1999;34(2-3):109–122. - PubMed
    1. Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology. 2005;64(6):973–975. - PubMed

Substances